| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J L O Rosa, P Brivio, D R Rossato, M B Fontoura, L E M Souza, F Fumagalli, F Calabrese, M E Burge. Tactile stimulation ameliorates haloperidol-induced movement disturbances in rats by promoting neuromodulation on dopaminergic and glutamatergic systems in nigrostriatal brain area. Progress in neuro-psychopharmacology & biological psychiatry. 2025-04-21. PMID:40258486. |
subsequently to a sub-chronic model of eps, ts reversed orofacial dyskinesia and movement impairments induced by hal and promoted beneficial modulations on dopaminergic and glutamatergic systems in nigrostriatal brain area. |
2025-04-21 |
2025-04-24 |
rat |
| Fan Zhang, Kai Gao, Junjiao Zhang, Sihan Li, Yue Li, Jingmin Wang, Ye Wu, Yuwu Jiang, Congying W. Bexarotene Promotes Neuroblastoma SH-SY5Y Cell Differentiation to Mature Neurons with Decreased Proliferation. Molecular neurobiology. 2025-04-14. PMID:40229457. |
sh-sy5y cells induced by bexarotene increased the expression of gabaergic marker glutamate decarboxylase (gad1) and dopaminergic marker th, but not glutamatergic marker glutamate-ammonia ligase (glul) and cholinergic marker solute carrier family 18 member 1 (slc18a1). |
2025-04-14 |
2025-04-17 |
human |
| Liwei Mao, Lian Wang, Zhihai Huang, Jian-Kang Chen, Lorelei Tucker, Quanguang Zhan. Comprehensive insights into emerging advances in the Neurobiology of anorexia. Journal of advanced research. 2025-04-03. PMID:40180244. |
anorexic behavior is regulated by cytokines, hormones (like gdf15, glp-1, and leptin), and neural circuits such as agrp, serotonergic, dopaminergic, and glutamatergic pathways. |
2025-04-03 |
2025-04-06 |
Not clear |
| David Anguizola, Alba Garcia Aragón, Brian Moncada, Diego Garcia-Borreguer. Restless Legs Syndrome: Neurochemistry and Therapy. Seminars in neurology. 2025-03-11. PMID:40068886. |
restless legs syndrome (rls) is a complex sensorimotor disorder characterized by disturbances in key neurochemical pathways, including dopaminergic, glutamatergic, and adenosinergic systems. |
2025-03-11 |
2025-03-14 |
Not clear |
| S Amrutha, Chandran S Abhinand, Shubham Sukerndeo Upadhyay, Ravishankar Parvaje, Thottethodi Subrahmanya Keshava Prasad, Prashant Kumar Mod. Network pharmacology and metabolomics analysis of Tinospora cordifolia reveals BACE1 and MAOB as potential therapeutic targets for neuroprotection in Alzheimer's disease. Scientific reports. vol 15. issue 1. 2025-03-08. PMID:40057579. |
pathway analysis highlighted the enrichment of camp, mtor, mapk, and pi3k-akt signaling pathways along with cholinergic, dopaminergic, serotonergic, glutamatergic synapse, and apoptosis. |
2025-03-08 |
2025-03-12 |
human |
| Junia Lara de Deus, Juliana Marino Maia, Renato Nery Soriano, Mateus R Amorim, Luiz G S Branc. Psychedelics in neuroinflammation: Mechanisms and therapeutic potential. Progress in neuro-psychopharmacology & biological psychiatry. 2025-02-01. PMID:39892847. |
beyond the serotonergic system, other neurotransmitter systems-including the glutamatergic, dopaminergic, noradrenergic, gamma-aminobutyric acid (gabaergic), and cholinergic systems-also play significant roles in mediating the effects of psychedelics. |
2025-02-01 |
2025-02-04 |
Not clear |
| Judy Cheng, Ellen T Koch, Daniel Ramandi, James P Mackay, Timothy P O'Leary, William Rees-Jones, Lynn A Raymon. Synaptic modulation of glutamate in striatum of the YAC128 mouse model of Huntington disease. Neurobiology of disease. 2024-12-24. PMID:39716682. |
d2 receptors are also expressed on glutamatergic cortical terminals, cholinergic interneurons, and dopaminergic terminals from substantia nigra where they suppress release of glutamate, acetylcholine and dopamine, respectively, and these cell types may contribute to early striatal dysfunction in hd. |
2024-12-24 |
2024-12-26 |
mouse |
| Jia Li, Yiyong Wei, Jiaxin Xiang, Donghang Zhan. Role of the ventral tegmental area in general anesthesia. European journal of pharmacology. 2024-11-20. PMID:39566814. |
the majority of vta neurons are dopaminergic neurons, although there is a significant proportion of gabaergic neurons and few glutamatergic neurons. |
2024-11-20 |
2024-11-23 |
Not clear |
| Martina Cuccarelli, Alessandro Zampogna, Antonio Supp. The broad spectrum of malignant syndromes. Neurobiology of disease. 2024-11-14. PMID:39542220. |
while distinct mechanisms may initially trigger the different malignant syndromes, a final common pathway leading to similar signs and symptoms involves various neurotransmitter systems, including dopaminergic, serotonergic, gabaergic, glycinergic, and glutamatergic pathways. |
2024-11-14 |
2024-11-17 |
Not clear |
| Ben-Hur Souto das Neves, Karine Ramires Lima, Ana Carolina de Souza da Rosa, Guilherme Liao, Anna Cecília Perretto, Guilherme Salgado Carrazoni, Pâmela Billig Mello-Carpe. Effects of NMDA glutamatergic receptors pharmacological stimulation of the ventral tegmental area on the memory deficits induced by maternal deprivation. Brain research. 2024-11-10. PMID:39522742. |
we hypothesized that pharmacological stimulation of dopaminergic neurons in vta by the infusion of an n-methyl-d-aspartate (nmda) receptors agonist (used considering the wide distribution of these glutamatergic receptors in the vta neurons) can reverse md-induced memory deficits. |
2024-11-10 |
2024-11-17 |
rat |
| Pascal Grumbach, Jan Kasper, Joerg F Hipp, Anna Forsyth, Sofie L Valk, Suresh Muthukumaraswamy, Simon B Eickhoff, Leonhard Schilbach, Juergen Dukar. Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changes. medRxiv : the preprint server for health sciences. 2024-11-06. PMID:39502665. |
these lcor alterations negatively co-localized with dopaminergic (d1, d2, dat), glutamatergic (nmda, mglur5), gabaergic (gabaa) and cholinergic neurotransmission (vacht). |
2024-11-06 |
2024-11-08 |
human |
| Huize Pang, Xiaolu Li, Ziyang Yu, Hongmei Yu, Shuting Bu, Juzhou Wang, Mengwan Zhao, Yu Liu, Yueluan Jiang, Guoguang Fa. Disentangling gray matter atrophy and its neurotransmitter architecture in drug-naïve Parkinson's disease: an atlas-based correlation analysis. Cerebral cortex (New York, N.Y. : 1991). vol 34. issue 10. 2024-10-18. PMID:39420471. |
cognitively impaired parkinson's disease patients showed gray matter atrophy in the left middle temporal atrophy, which is associated with serotoninergic, dopaminergic, cholinergic, and glutamatergic receptors (fdr-p < 0.05). |
2024-10-18 |
2024-10-20 |
Not clear |
| Kanghoon Jung, Sarah Krüssel, Sooyeon Yoo, Myungmo An, Benjamin Burke, Nicholas Schappaugh, Youngjin Choi, Zirong Gu, Seth Blackshaw, Rui M Costa, Hyung-Bae Kwo. Dopamine-mediated formation of a memory module in the nucleus accumbens for goal-directed navigation. Nature neuroscience. 2024-09-28. PMID:39333785. |
converging dopaminergic and hippocampal glutamatergic inputs to the nac mediate the formation of a goal-related memory within a subpopulation of nac neurons during shelter experiences. |
2024-09-28 |
2024-10-01 |
mouse |
| Michael Aschner, Anatoly V Skalny, Rongzhu Lu, Airton C Martins, Aristidis Tsatsakis, Sergey A Miroshnikov, Abel Santamaria, Alexey A Tinko. Molecular mechanisms of zinc oxide nanoparticles neurotoxicity. Chemico-biological interactions. 2024-09-15. PMID:39278458. |
znonps exposure is associated with altered cholinergic, dopaminergic, serotoninergic, as well as glutamatergic and γ-aminobutyric acid (gaba)-ergic neurotransmission, thus contributing to impaired neuronal signal transduction. |
2024-09-15 |
2024-09-18 |
human |
| Charalampos Brakatselos, Alexia Polissidis, George Ntoulas, Michail-Zois Asprogerakas, Olga Tsarna, Anastasia Vamvaka-Iakovou, Gerasimos Nakas, Anastasios Delis, Petros Tzimas, Leandros Skaltsounis, Joana Silva, Foteini Delis, Joao Filipe Oliveira, Ioannis Sotiropoulos, Katerina Antonio. Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2024-09-06. PMID:39242923. |
repeated ket model is characterized by schizophrenia-like symptomatology and alterations in glutamatergic and dopaminergic activity mainly in the pfc and the dorsomedial striatum (dms), through a bi-directional pattern. |
2024-09-06 |
2024-09-10 |
rat |
| Ehsan Raeis-Abdollahi, Payman Raise-Abdullahi, Ali Rashidy-Pour, Morvarid Meamar, Hassan Askar. Coffee's protective mechanisms against neurodegeneration. Progress in brain research. vol 288. 2024-08-21. PMID:39168556. |
coffee modulates neurotransmitter systems, including dopaminergic, cholinergic, and glutamatergic pathways implicated in neurodegeneration. |
2024-08-21 |
2024-08-24 |
Not clear |
| Triana Acevedo-Huergo, Jonathan Sánchez-Yépez, María Soledad Mendoza-Trejo, Isela Hernández-Plata, Magda Giordano, Verónica Mireya Rodrígue. Hypoactivity and neurochemical alterations in the basal ganglia of female Sprague-Dawley rats after repeated exposure to atrazine. Frontiers in toxicology. vol 6. 2024-08-20. PMID:39161789. |
several studies have classified atr as an endocrine disruptor, and it has been found to have neurotoxic effects on behavior, along with alterations in the dopaminergic, gabaergic, and glutamatergic systems in the basal ganglia of male rodents. |
2024-08-20 |
2024-08-22 |
rat |
| Peng Feng, Yuanhuan Chen, Kexin Sun, Xing Wei, Yanqin Ding, Jing Shang, Zheng Gang Shi, Xiaomin Xu, Junxiong Guo, Yongyan Tia. Volatile oil from Acori graminei Rhizoma affected the synaptic plasticity of rats with tic disorders by modulating dopaminergic and glutamatergic systems. Journal of ethnopharmacology. 2024-08-15. PMID:39147000. |
volatile oil from acori graminei rhizoma affected the synaptic plasticity of rats with tic disorders by modulating dopaminergic and glutamatergic systems. |
2024-08-15 |
2024-08-18 |
rat |
| Vasiliki Epameinondas Georgakopoulou, Pagona Sklapani, Nikolaos Trakas, Russel J Reiter, Demetrios A Spandido. Exploring the association between melatonin and nicotine dependence (Review). International journal of molecular medicine. vol 54. issue 4. 2024-08-02. PMID:39092582. |
melatonin may influence neurotransmitter systems involved in addiction, such as the dopaminergic, glutamatergic, serotonergic and endogenous opioid systems. |
2024-08-02 |
2024-08-05 |
Not clear |
| Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska, Dagmara Mirowska-Guzel, Agnieszka Cudnoch-Jędrzejewsk. Psilocybin in pharmacotherapy of obsessive-compulsive disorder. Pharmacological reports : PR. 2024-08-01. PMID:39088105. |
pharmacological treatment includes drugs affecting the serotoninergic, dopaminergic, and glutamatergic systems, such as selective serotonin reuptake inhibitors (ssris). |
2024-08-01 |
2024-08-03 |
Not clear |